Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocationsPAWELEC, G; KALBACHER, H; BRUSERUD, O et al.Oncology research. 1992, Vol 4, Num 8-9, pp 315-320, issn 0965-0407Article

Expression of myeloid-specific antigens on two human erythroleukaemia cell lines HEL and K562 = Expression des antigènes myéloïdes spécifiques sur deux lignées érythroleucémiques humaines HEL et K562RIMMER, E. F; HORTON, M. A.Leukemia research. 1984, Vol 8, Num 2, pp 207-211, issn 0145-2126Article

A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts = Un antigène spécifique de la cellule de Hodgkin est exprimé sur une sous-population de lymphoblastes T (helper) auto- et alloactivésANDREESEN, R; OSTERHOLZ, J; LÖHR, G. W et al.Blood. 1984, Vol 63, Num 6, pp 1299-1302, issn 0006-4971Article

Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation = Expression des antigènes associés aux cellules B humaines dans les leucémies et lymphomes: un modèle de différenciation de cellules B humainesANDERSON, K. C; BATES, M. P; SLAUGHENHOUPT, B. L et al.Blood. 1984, Vol 63, Num 6, pp 1424-1433, issn 0006-4971Article

The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine modelJINBO FANG; GUIYUN WANG; QIONG YANG et al.Vaccine. 2005, Vol 23, Num 40, pp 4860-4866, issn 0264-410X, 7 p.Article

Cancer immunotherapy in clinical oncologyKNUTH, A; JÄGER, D; JÄGER, E et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, pp S46-S51, issn 0344-5704, SUPConference Paper

Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancerTEH YU WANG; KAWAGUCHI, T. P.Annals of clinical and laboratory science. 1986, Vol 16, Num 6, issn 0091-7370, 461Article

A prospective postoperative evaluation of urinary tumor-associated antigens in sarcoma patients: correlation with disease recurrence = Une évaluation postopératoire prospective du taux d'antigènes urinaires associés aux tumeurs chez les sujets porteurs de sarcome. Corrélation avec la récidive tumoraleHUTH, J. F; GUPTA, R. K; EILBER, F. R et al.Cancer. 1984, Vol 53, Num 6, pp 1306-1310, issn 0008-543XArticle

Immunohistochemical analysis of the A4 and AO10 (gp110) cell-surface antigens of human astrocytomaGARIN-CHESA, P; BERESFORD, H. R; WALKER, S et al.The American journal of pathology. 1990, Vol 136, Num 4, pp 797-807, issn 0002-9440Article

In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinomaTAKAHASHI, H; OZTURK, M; WILSON, B et al.Hepatology (Baltimore, Md.). 1989, Vol 9, Num 4, pp 625-634, issn 0270-9139Article

A new breast carcinoma antigen defined by a monoclonal antibodySTACKER, S. A; THOMPSON, C; RIGLAR, C et al.Journal of the National Cancer Institute. 1985, Vol 75, Num 5, pp 801-811, issn 0027-8874Article

Surface antigen expression by a human B-lymphoblastoid cell line treated with differentiation inducers, dimethylsulfoxide and tetradecanoylphorbol acetateASHMAN, L. K; GESCHE, A. H.Leukemia research. 1985, Vol 9, Num 1, pp 157-165, issn 0145-2126Article

OXIDATIVE METABOLISM, CYTOSKELETAL SYSTEM, AND CALCIUM ENTRY OF LEUKOCYTES IN THE PHENOMENON OF SENSITIZING CANCER EXTRACT-INDUCED LEUKOCYTE ADHERENCE INHIBITION = LE METABOLISME OXYDATIF, LE SYSTEME DU CYTOSQUELETTE, ET L'ENTREE DU CALCIUM DES LEUCOCYTES DANS LE PHENOMENE D'INHIBITION D'ADHERENCE DES LEUCOCYTES INDUIT PAR UN EXTRAIT CANCEREUX SENSIBILISANTTHOMSON DMP; PHELAN K; SCANZANO R et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1066-1073; ABS. ENG; BIBL. 47 REF.; GRAPHArticle

THE USE OF ANTIKERATIN ANTIBODIES IN THE DIAGNOSIS OF HUMAN NEOPLASMS = L'EMPLOI DES ANTICORPS ANTIKERATINE DANS LE DIAGNOSTIC DES CANCERS HUMAINSNAGLE RB; MCDANIEL KM; CLARK VA et al.1983; AMERICAN JOURNAL OF CLINICAL PATHOLOGY; ISSN 0002-9173; USA; DA. 1983; VOL. 79; NO 4; PP. 458-466; ABS. ENG; BIBL. 17 REF.; GRAPH, FIGArticle

L'immunothérapie adoptive des tumeurs solides enfin réhabilitée = Adoptive immunotherapy in cancer: new hopesJOTEREAU, Francine; LABARRIERE, Nathalie; GERVOIS, Nadine et al.MS. Médecine sciences. 2003, Vol 19, Num 3, pp 268-270, issn 0767-0974, 3 p.Article

Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unitSHIMIZU, J; ZOU, J.-P; IKEGAME, K et al.Japanese journal of cancer research. 1991, Vol 82, Num 3, pp 262-265, issn 0910-5050Article

Prostate-specific antigne and prostatic acid phosphatase : biomolecular and physiologic characteristicsBILHARTZ, D. L; TINDALL, D. J; OESTERLING, J. E et al.Urology (Ridgewood, NJ). 1991, Vol 38, Num 2, pp 95-102, issn 0090-4295Article

Investigation of expression of 5T4 antigen in cervical cancerJONES, H; ROBERTS, G; HOLE, N et al.British journal of cancer. 1990, Vol 61, Num 1, pp 96-100, issn 0007-0920Article

Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the protateBARAK, M; MECZ, Y; LURIE, A et al.The Journal of laboratory and clinical medicine. 1989, Vol 113, Num 5, pp 598-603, issn 0022-2143Article

Evaluation of prostate-specific antigen in untreated prostatic carcinomaOOSTEROM, R; BOGDANOWICZ, J; SCHRÖDER, F. H et al.European urology. 1989, Vol 16, Num 4, pp 253-257, issn 0302-2838Article

L'antigène prostatique spécifique = Specific prostatic antigenBOCCON-GIBOD, L.La Semaine des hôpitaux de Paris. 1989, Vol 65, Num 5, pp 245-246, issn 0037-1777Article

Intracellular distribution of pancreatic tumor antigen purified from BHP-induced adenocarcinomas in Syrian hamstersMATSUZAKI, M; NATORI, T; MIZUMOTO, K et al.Pancreas. 1989, Vol 4, Num 4, pp 429-435, issn 0885-3177Article

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III: Radiation treated patientsSTAMEY, T. A; KABALIN, J. N; FERRARI, M et al.The Journal of urology. 1989, Vol 141, Num 5, pp 1084-1087, issn 0022-5347Article

Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancerHETHERINGTON, J. W; SIDDALL, J. K; COOPER, E. H et al.European urology. 1988, Vol 14, Num 1, pp 1-5, issn 0302-2838Article

L'antigène spécifique de la prostate en pathologie prostatique = Prostate-specific antigen in prostate disordersTEILLAC, P; PEYRET, C; LEROY, M et al.Annales d'urologie. 1988, Vol 22, Num 3, pp 193-196, issn 0003-4401Article